NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bolt Biotherapeutics Inc (NASDAQ: BOLT)

 
BOLT Technical Analysis
5
As on 25th Jan 2022 BOLT Share Price closed @ 3.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 17.36 & Strong Sell for SHORT-TERM with Stoploss of 30.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOLT Share Price

Open 3.81 Change Price %
High 4.03 1 Day 0.10 2.58
Low 3.74 1 Week 0.19 5.01
Close 3.98 1 Month -0.67 -14.41
Volume 135685 1 Year -28.17 -87.62
52 Week High 39.93 | 52 Week Low 3.61
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
BOLT
Daily Charts
BOLT
Intraday Charts
Whats New @
Bazaartrend
BOLT
Free Analysis
 
BOLT Important Levels Intraday
RESISTANCE4.54
RESISTANCE4.36
RESISTANCE4.25
RESISTANCE4.14
SUPPORT3.82
SUPPORT3.71
SUPPORT3.60
SUPPORT3.42
 
BOLT Target for Month January
4th UP TARGET45.82
3rd UP TARGET32.4
2nd UP TARGET24.11
1st UP TARGET15.81
1st DOWN TARGET-7.85
2nd DOWN TARGET-16.15
3rd DOWN TARGET-24.44
4th DOWN TARGET-37.86
 
BOLT Weekly Target
4th UP TARGET15.31
3rd UP TARGET11.68
2nd UP TARGET9.43
1st UP TARGET7.18
1st DOWN TARGET0.78
2nd DOWN TARGET-1.47
3rd DOWN TARGET-3.72
4th DOWN TARGET-7.35
 
BOLT Target for Year 2022
4th UP TARGET80.54
3rd UP TARGET55.99
2nd UP TARGET40.81
1st UP TARGET25.63
1st DOWN TARGET-17.67
2nd DOWN TARGET-32.85
3rd DOWN TARGET-48.03
4th DOWN TARGET-72.58
 
 
BOLT Other Details
Segment EQ
Market Capital 475061888.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOLT Address
BOLT
 
BOLT Latest News
 
Your Comments and Response on Bolt Biotherapeutics Inc
 
BOLT Business Profile
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California. Address: 900 Chesapeake Drive, Redwood City, CA, United States, 94063
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service